Document is current
Any future updates will be listed below
-
Authors
Kotheeranurak, Vit https://orcid.org/0000-0002-9593-429X
Tangdamrongtham, Thanadol https://orcid.org/0000-0002-4215-8880
Lin, Guang-Xun https://orcid.org/0000-0002-9828-2768
Singhatanadgige, Weerasak https://orcid.org/0000-0001-7166-1381
Limthongkul, Worawat https://orcid.org/0000-0002-0116-8791
Yingsakmongkol, Wicharn https://orcid.org/0000-0002-8784-7604
Kim, Jin-Sung https://orcid.org/0000-0001-5086-0875
Jitpakdee, Khanathip https://orcid.org/0000-0002-5955-0037
- License Information
-
More Information
Article History
Received: 21 November 2022
Revised: 21 November 2022
Accepted: 23 March 2023
First Online: 3 April 2023
Declarations
:
: JSK is currently a consultant for RIWOSpine, GmbH, Germany, and Elliquence, LLC, USA. WS and WL are currently speakers for Medtronic company. For the remaining authors, none were declared.
: The trial was registered at the Thai Clinical Trials Registry (TCTR2019217001). Institutional review board (IRB) approval was obtained from the Queen Savang Vadhana Memorial Hospital.
: All participants provided oral and written informed consent.
